ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Andrew J. Parry
Doff B. McElhinney
Frank L. Hanley
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parry, A. J.
Right arrow Articles by Hanley, F. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parry, A. J.
Right arrow Articles by Hanley, F. L.

Ann Thorac Surg 2000;70:582-589
© 2000 The Society of Thoracic Surgeons


Original articles: cardiovascular

Neutrophil degranulation and complement activation during fetal cardiac bypass

Andrew J. Parry, FRCSa, Edwin Petrossian, MDa, Doff B. McElhinney, MDa, V. Mohan Reddy, MDa, Frank L. Hanley, MDa

a Department of Pediatric Cardiac Surgery, University of California, San Francisco, San Francisco, California, USA

Address reprint requests to Dr Parry, Department of Paediatric Cardiac Surgery, Bristol Royal Hospital for Sick Children, St Michael’s Hill, BS2 8BJ Bristol, UK
e-mail: ajparry{at}yahoo.co.uk

Background. Fetal cardiac bypass results in dysfunction of the fetoplacental unit (FPU) characterized by increased placental vascular resistance and respiratory acidosis. However the mechanisms of this dysfunction are not completely understood. To test the hypothesis that complement activation and neutrophil degranulation may contribute to the placental dysfunction associated with fetal bypass, we compared placental hemodynamics, complement activation, and neutrophil degranulation among fetuses exposed to cardiac bypass with a miniaturized bypass circuit including an in-line axial flow pump (Hemopump), fetuses undergoing bypass with a conventional roller pump circuit, and control fetuses that were similarly exposed but did not undergo bypass.

Methods. Twenty-six Western Cross sheep fetuses (median 122 days gestation) were randomly assigned to undergo cardiac bypass for 30 minutes with the Hemopump circuit (n = 8), to undergo bypass for 30 minutes with the conventional (roller pump) circuit (n = 10), or to undergo identical exposure and cannulation but not bypass (n = 8, controls). Blood samples were collected to measure white cell count and differential, and C3a and lactoferrin levels prior to bypass, at the end of bypass, and 1 and 2 hours after bypass. Hemodynamics and blood gases were also monitored.

Results. There was a fall in white cell count over time that continued after bypass in all groups; neutrophils and lymphocytes were affected similarly. C3a levels rose significantly from prebypass to postbypass in the roller pump group (p < 0.0001) but not in either of the other groups. Lactoferrin levels rose significantly from start of bypass in both bypass groups (Hemopump p = 0.01; roller pump p < 0.0001) but not in controls. The elevation in lactoferrin level coincided with worsening placental gas exchange and deteriorating cardiac function.

Conclusions. Complement and neutrophil activation occurred with fetal cardiac bypass but only neutrophil activation mirrored the FPU and cardiac dysfunction, suggesting that products of neutrophil activation may be important contributing factors. Improved FPU function with a bypass circuit that has less extracorporeal surface and does not require a large priming volume may be due in part to a reduction in the magnitude of this inflammatory response.




This article has been cited by other articles:


Home page
PerfusionHome page
J. Lombardi, J. Sedgwick, J. Schenbeck, W. Lubbers, R. E Ferguson, A. Gardner, J. L McNamara, and P. Eghtesady
Cardiopulmonary bypass in the immature fetus through novel use of a mini-centrifugal pump
Perfusion, May 1, 2006; 21(3): 185 - 191.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Karamlou, J. M. Schultz, C. Silliman, C. Sandquist, J. You, I. Shen, and R. M. Ungerleider
Using a Miniaturized Circuit and an Asanguineous Prime to Reduce Neutrophil-Mediated Organ Dysfunction Following Infant Cardiopulmonary Bypass
Ann. Thorac. Surg., July 1, 2005; 80(1): 6 - 14.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. Ikai, R. K. Riemer, C. Ramamoorthy, S. Malhatra, L. Cassorla, G. Amir, F. L. Hanley, and V. M. Reddy
Preliminary results of fetal cardiac bypass in nonhuman primates
J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 175 - 181.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y. Oishi, M. Masuda, T. Yasutsune, N. Boku, S. Tokunaga, S. Morita, and H. Yasui
Impaired Endothelial Function of the Umbilical Artery After Fetal Cardiac Bypass
Ann. Thorac. Surg., December 1, 2004; 78(6): 1999 - 2003.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. Carotti, F. Emma, S. Picca, E. Iannace, S. B. Albanese, M. Grigioni, F. Meo, M. Sciarra, and R. M. Di Donato
Inflammatory response to cardiac bypass in ewe fetuses: effects of steroid administration or continuous hemodiafiltration
J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1839 - 1848.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 by The Society of Thoracic Surgeons.